Who
Vincent J. Angotti
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Talphera.
In numbers
- Trades disclosed
- 66
- Buys
- 20
- Sells
- 0
- Bought
- $757K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Mar 2017
- Last trade
- 2 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 3 Apr 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $7,1789,938 at $0.7223 | filing |
| 2 Apr 2026filed 3 Apr 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $7,1559,938 at $0.72 | filing |
| 13 Mar 2026filed 25 Mar 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $125K213,310 at $0.586 | filing |
| 13 Mar 2026filed 25 Mar 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $126K213,310 at $0.59 | filing |
| 14 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $7,5849,559 at $0.7934 | filing |
| 14 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $7,5529,559 at $0.79 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $86K105,364 at $0.8123 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —594,000 at $0.00 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —594,000 at $0.00 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $85K105,364 at $0.81 | filing |
| 10 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,6583,179 at $0.8361 | filing |
| 10 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,6703,179 at $0.84 | filing |
| 2 Apr 2025filed 3 Apr 2025 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —365,000 at $0.00 | filing |
| 2 Apr 2025filed 3 Apr 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $126K213,310 at $0.59 | filing |
| 2 Apr 2025filed 3 Apr 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —61,000 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $7,08510,575 at $0.67 | filing |
| 11 Feb 2025filed 12 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,1813,517 at $0.62 | filing |
| 10 Feb 2025filed 12 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,2143,515 at $0.63 | filing |
| 5 Dec 2024filed 6 Dec 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $3,2005,000 at $0.64 | filing |
| 27 Nov 2024filed 2 Dec 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $3,6505,000 at $0.73 | filing |
News
Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonTLPH · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Vincent J. Angotti; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.